Immune Response News and Research

RSS
Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Research teases out connection between diet, immune response, gut bacteria and multiple sclerosis

Research teases out connection between diet, immune response, gut bacteria and multiple sclerosis

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

French project takes an extra step in the development of nasal vaccine candidate against COVID-19

French project takes an extra step in the development of nasal vaccine candidate against COVID-19

Risk of long COVID-19 predicted by immunoglobulin signature

Risk of long COVID-19 predicted by immunoglobulin signature

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Omicron RBD mutations increase ACE2 binding and reduce antibody sensitivity

Omicron RBD mutations increase ACE2 binding and reduce antibody sensitivity

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Microbiome 'profiling' may help identify people at risk of long COVID

Microbiome 'profiling' may help identify people at risk of long COVID

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

Anti-SARS-CoV-2 antibodies found in wild mustelids in France

Anti-SARS-CoV-2 antibodies found in wild mustelids in France

Understanding immune responses to SARS-CoV-2 infections in children

Understanding immune responses to SARS-CoV-2 infections in children

SARS-CoV-2 virus co-opts intrinsic cellular machinery to suppress interferon production

SARS-CoV-2 virus co-opts intrinsic cellular machinery to suppress interferon production

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Pharmacies are turning away immunocompromised patients seeking 4th covid shot

Pharmacies are turning away immunocompromised patients seeking 4th covid shot